Navigation Links
Addiction Drug May Help Ease Fibromyalgia
Date:4/17/2009

In small study, naltrexone offered some women relief

FRIDAY, April 17 (HealthDay News) -- Low doses of an inexpensive drug called naltrexone -- already used for years to treat drug addiction -- helped reduce pain and fatigue in women with the painful disorder fibromyalgia, a new study has found.

"Physicians have been using this off-label for a while," said study co-author Jarred Younger, an instructor in anesthesia and pain medicine at Stanford University School of Medicine. The findings were published online April 17 in the journal Pain Medicine.

Fibromyalgia is a chronic ailment, marked by musculoskeletal pain and sensitivity to being touched. Some experts say it may affect up to 4 percent of the population.

Three prescription drugs are also on the market to treat fibromyalgia, Younger said. But, he added, "the three drugs don't solve the problem for everyone. Some don't respond to any of these drugs."

Younger said he got the idea to study naltrexone after hearing that some other doctors had success with it and after hearing from some members of fibromyalgia support groups that it had worked for them.

While the results of the small study look promising, Younger said it's too early to recommend the drug until more research is in.

In the study, he gave all 10 women a handheld computer and told them to enter daily reports of pain and other symptoms, describing them all on a scale of not bad to worst. The women were taken off their current fibromyalgia medication, then began to take placebo for two weeks (although they did not know it was placebo). Next they took naltrexone for 8 weeks. They then went through a two-week ''washout" period.

The researchers then evaluated their symptoms. "The drug reduced symptoms by 30 percent compared to placebo," Younger said. It was a statistically significant difference, he said.

That was an overall result, and the drug worked better for some than others. "Six out of the 10 were strong respondents, with at least a 50 percent reduction in symptoms," Younger said. It didn't work for all 10 women, he said, and some did not respond at all.

Naltrexone also seemed to ease certain symptoms more than others. "The drug helped daily pain -- the higher levels of pain, fatigue and stress," Younger said.

One symptom that did not typically improve was "fibro fog," the foggy thinking associated with the disorder, sleep quality, headaches, gastrointestinal problems and sadness.

Exactly how the drug works is not known for sure, Younger said. One possibility is that naltrexone quiets down a hyperactive immune system, he said.

Younger is continuing the research, and if the good results seen here bear out, naltrexone may be a good alternative for some patients. "It's a small dose, and we saw very few side effects," he said. The most typical was vivid dreaming.

Naltrexone has another point in its favor: cost. Doses of the drug, which must be gotten from special "compounding" pharmacies, total about $40 a month, Younger said.

Another expert called the study "fascinating."

"I was pleased to see that they had such a nice response to the therapy," said Dr. Patrick Wood, a family medicine physician with a specialty practice in fibromyalgia in Renton, Wash. He serves as medical adviser for the National Fibromyalgia Association.

The study was small, he said, but scientifically sound. If more research is promising, naltrexone may eventually be a competitor to higher-priced fibromyalgia drugs now on the market, Wood said.

More information

To learn more about fibromyalgia, visit the National Fibromyalgia Association.



SOURCES: Jarred Younger, Ph.D., instructor, anesthesia and pain medicine, Stanford University School of Medicine, Stanford, Calif; Patrick Wood, M.D., senior medical adviser, National Fibromyalgia Association, and family medicine physician with a specialty practice in fibromyalgia, Renton, Wash.; April 17, 2009, Pain Medicine, online


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Nice but naughty -- our addiction to chocolate
2. U of M study: Health food supplement may curb addiction of pathological gamblers
3. Joint NJ/NY Rally for Addiction Recovery to Be Hub of Events Nationwide
4. Initial reaction to nicotine can dictate addiction
5. Leaders in addiction treatment announce national ACTION campaign
6. Rat Study Gets at Root of Nicotine Addiction
7. Shopping Sprees Can Cost More Than You Think: How to Identify a Shopping Addiction
8. Brain Region Tied to Amphetamine Addiction
9. Nicotine addiction slashed in test of new cigarette smoking strategy
10. VH1 Teams Up with Dr. Drew for Celebrity Rehab With Dr. Drew, a Series Depicting the Process of Overcoming Addiction
11. Mental illness and drug addiction may co-occur due to disturbance in part of the brain
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Addiction Drug May Help Ease Fibromyalgia
(Date:6/25/2016)... ... 2016 , ... Experts from the American Institutes for Research ... June 26-28, 2016, at the Hynes Convention Center in Boston. , AIR experts ... planning, healthcare costs and patient and family engagement. , AIR researchers will be ...
(Date:6/25/2016)... Lewisville, TX (PRWEB) , ... June 25, 2016 , ... ... in the United States, named Dr. Sesan Ogunleye, as the Medical Director of its ... be the facility Medical Director of our new Mesquite location,” said Dr. James M. ...
(Date:6/25/2016)... Montreal, Canada (PRWEB) , ... June 25, 2016 , ... ... the pursuit of success. In terms of the latter, setting the bar too high ... low, risk more than just slow progress toward their goal. , Research from ...
(Date:6/24/2016)... ... 2016 , ... Marcy was in a crisis. Her son James, eight, was out of control. ... and physically. , “When something upset him, he couldn’t control his emotions,” remembers Marcy. ... rocks at my other children and say he was going to kill them. If ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... Comfort Keepers® ... American Cancer Society and the Road To Recovery® program to drive cancer patients to ... and other adults to ensure the highest quality of life and ongoing independence. ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... LONDON , June 23, 2016 ... environments  Oticon , industry leaders in ... the launch of Oticon Opn ™, the world,s ... world of possibilities for IoT devices.      ... Opn, Oticon introduces a number of ,world firsts,: ...
(Date:6/23/2016)... , June 23, 2016 Research ... "Surgical Procedure Volumes: Global Analysis (United States, China, Japan, ... report to their offering. ... tool for healthcare business planners, provides surgical procedure volume ... surgery trends with an in-depth analysis of growth drivers ...
(Date:6/23/2016)...  The National Pharmaceutical Council (NPC) today announced ... research organization as its newest member.  ... president and chief scientific officer, Mallinckrodt Pharmaceuticals, will ... Board of Directors. ... us in support of our efforts to conduct ...
Breaking Medicine Technology: